What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Disease
- Alzheimer's disease
His primary scientific interests are in Dementia, Alzheimer's disease, Pathology, Psychiatry and Degenerative disease.
His Dementia study is focused on Disease in general.
His Alzheimer's disease study combines topics from a wide range of disciplines, such as Neurodegeneration, Neuroscience, Immunology and Atrophy.
His Pathology research focuses on subjects like Positron emission tomography, which are linked to Brain mapping.
Hans Förstl focuses mostly in the field of Psychiatry, narrowing it down to topics relating to Meta-analysis and, in certain cases, Cognitive impairment, MEDLINE and Vitamin D and neurology.
In the field of Central nervous system disease and Internal medicine Hans Förstl studies Degenerative disease.
His most cited work include:
- Selective changes of resting-state networks in individuals at risk for Alzheimer's disease (825 citations)
- Analysis of Heterogeneous βA4 Peptides in Human Cerebrospinal Fluid and Blood by a Newly Developed Sensitive Western Blot Assay (490 citations)
- Frontotemporal lobar degeneration: demographic characteristics of 353 patients. (286 citations)
What are the main themes of his work throughout his whole career to date?
Hans Förstl mainly focuses on Dementia, Disease, Psychiatry, Internal medicine and Alzheimer's disease.
In his study, which falls under the umbrella issue of Dementia, Audiology is strongly linked to Cognition.
His research investigates the connection between Disease and topics such as Neuroscience that intersect with issues in Dementia with Lewy bodies.
His Psychiatry study frequently intersects with other fields, such as Clinical psychology.
Hans Förstl studied Internal medicine and Endocrinology that intersect with Amyloid precursor protein.
His Alzheimer's disease research integrates issues from Apolipoprotein E, Cerebrospinal fluid, Atrophy and Degenerative disease.
He most often published in these fields:
- Dementia (33.83%)
- Disease (23.95%)
- Psychiatry (22.47%)
What were the highlights of his more recent work (between 2014-2021)?
- Dementia (33.83%)
- Disease (23.95%)
- Psychiatry (22.47%)
In recent papers he was focusing on the following fields of study:
The scientist’s investigation covers issues in Dementia, Disease, Psychiatry, Neuroscience and Internal medicine.
His Dementia study introduces a deeper knowledge of Pathology.
The concepts of his Disease study are interwoven with issues in Neurology, Cerebrospinal fluid, Pediatrics and Risk analysis.
His research in Psychiatry intersects with topics in Distress and MEDLINE.
His Neuroscience research incorporates elements of Alzheimer's disease and In vivo.
His studies deal with areas such as Endocrinology, Oncology and Cardiology as well as Internal medicine.
Between 2014 and 2021, his most popular works were:
- Rescue of long-range circuit dysfunction in Alzheimer's disease models (105 citations)
- Decreased amyloid-β and increased neuronal hyperactivity by immunotherapy in Alzheimer's models (92 citations)
- Disrupted Intrinsic Networks Link Amyloid-β Pathology and Impaired Cognition in Prodromal Alzheimer's Disease (59 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Disease
- Alzheimer's disease
His primary areas of investigation include Dementia, Neuroscience, Alzheimer's disease, Disease and Pathology.
Dementia is a subfield of Internal medicine that Hans Förstl explores.
In his research, Cross-sectional study, Salud mental, Depression, Connectome and Psychosis is intimately related to Schizophrenia, which falls under the overarching field of Neuroscience.
His Alzheimer's disease research includes themes of Neocortex, Slow-wave sleep, Amyloid β and In vivo.
His Disease research incorporates themes from Risk analysis and Relevance.
His Pathology research includes elements of Fluorodeoxyglucose and Positron emission tomography.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
